Skip to main content

Table 3 ECG evaluation using II. lead

From: Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy

 

CON

STZ

ECG parameters (n)

10

9

Heart rate (bpm)

349 ± 16

297 ± 8.9*

R –R (ms)

175 ± 8.2

203 ± 6.1*

P –wave (ms)

23 ± 1.5

23 ± 0.8

P-Q interval (ms)

49 ± 3.1

55 ± 2.8

QRS interval (ms)

16 ± 0.4

18 ± 0.7*

T- wave (ms)

49 ± 3.2

64 ± 2.6*

QT (ms)

64 ± 3.1

83 ± 2.5*

QTc (ms)

69 ± 3.2

82 ± 2.6*

P amplitude (mV)

0.09 ± 0.01

0.15 ± 0.01*

R amplitude (mV)

0.6 ± 0.05

0.9 ± 0.06*

T amplitude (mV)

0.14 ± 0.01

0.26 ± 0.03*

  1. Mean ± SEM, *p < 0.05 versus CON
  2. CON—controls, STZ—streptozotocin administered diabetic rats